2013
DOI: 10.1016/j.ijid.2012.11.005
|View full text |Cite
|
Sign up to set email alerts
|

Listeria monocytogenes septic arthritis in a patient treated with mycophenolate mofetil for polyarteritis nodosa: a case report and review of the literature

Abstract: Listeriosis can be a cause of arthritis. Here, we present a case of Listeria monocytogenes septic arthritis of the right hip in a 66-year-old male treated with mycophenolate mofetil for polyarteritis nodosa. So far, septic arthritis due to this microorganism has not been reported in patients treated with mycophenolate mofetil. We review the literature of L. monocytogenes septic arthritis and discuss the role of mycophenolate mofetil treatment in precipitating listeriosis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
10
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(10 citation statements)
references
References 6 publications
0
10
0
Order By: Relevance
“…A variety of cases of infectious complication in patients treated with azathioprine and mycophenolate mofetil have been published. Bacterial infections (common and atypical bacterial infections including Listeria monocytogenes , and mycobacterium species), fungal infections ( Cryptococcus neoformans, Aspergillus , Mucor , Pneumocystis jirovecii ), parasitic infection/reactivation ( Toxoplasma gondii ), and viral infection/reactivation (disseminated herpes zoster, varicella reactivation, JC virus, and polyomavirus associated nephropathy associated with BK virus infection) have been reported in azathioprine and mycophenolate mofetil users . The FDA places a special emphasis on the risk of JC virus‐associated progressive multifocal leukoencephalopathy in azathioprine and mycophenolate mofetil users .…”
Section: Other Immunosuppressive Drugsmentioning
confidence: 99%
“…A variety of cases of infectious complication in patients treated with azathioprine and mycophenolate mofetil have been published. Bacterial infections (common and atypical bacterial infections including Listeria monocytogenes , and mycobacterium species), fungal infections ( Cryptococcus neoformans, Aspergillus , Mucor , Pneumocystis jirovecii ), parasitic infection/reactivation ( Toxoplasma gondii ), and viral infection/reactivation (disseminated herpes zoster, varicella reactivation, JC virus, and polyomavirus associated nephropathy associated with BK virus infection) have been reported in azathioprine and mycophenolate mofetil users . The FDA places a special emphasis on the risk of JC virus‐associated progressive multifocal leukoencephalopathy in azathioprine and mycophenolate mofetil users .…”
Section: Other Immunosuppressive Drugsmentioning
confidence: 99%
“…Listeriosis is a serious foodborne disease caused by Listeria monocytogenes , predominantly affecting people with weakened immune systems including neonates, pregnant women, elderly and immunocompromised individuals leading to serious illness with high mortality rates ( European Food Safety Authority [EFSA], 2017 ; Centers for Disease Control [CDC], 2018 ; Radoshevich and Cossart, 2018 ). Although infections usually manifest as meningitis, bacteremia, and feto-maternal complications, listeriosis can in rare cases present as focal infections in different organs including bone and joint ( Allerberger and Wagner, 2010 ; Del Pozo et al, 2013 ; Chavada et al, 2014 ; European Food Safety Authority [EFSA], 2017 ; Radoshevich and Cossart, 2018 ). Septic arthritis is one of infrequent listeriosis manifestation that usually involves orthopedic implant devices and it is more common in older or immunosuppressed individuals ( Cone et al, 2001 ; Chougle and Narayanaswamy, 2004 ; Kesteman et al, 2007 ; Charlier et al, 2012 ; Del Pozo et al, 2013 ; Chavada et al, 2014 ; Bush et al, 2015 ; Bader et al, 2016 ).…”
Section: Introductionmentioning
confidence: 99%
“…Additional high-risk populations include those with hematologic malignancy, end-stage renal disease, AIDS, organ transplantation, iron-overload states, alcoholism and other chronic liver diseases [ 3 , 8 ]. In particular, the risk of invasive Listeriosis is noted with the use of TNF-α inhibitors as it suppresses T-cell mediated immunity; the primary defence against this organism [ 10 12 ].…”
Section: Discussionmentioning
confidence: 99%